Cipla | CIPLA - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Arca Biopharma USD 4.6M 4.1M 2026-03
aTyr Pharma 69.82M 9.83M 2026-06
Bio Path 677K 547K 2026-03
Capricor Therapeutics 3.05M 2.46M 2025-12
Cara Therapeutics -89.64M 128.67M 2025-12
Cipla INR 170.3M 39M 2026-06
Dr.Reddys Laboratories INR 1.26B 198M 2026-06
Immunic 197K 222K 2025-12
Minerva Neurosciences USD 2.31M 60K 2024-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Sangamo BioSciences 97.56M 11.39M 2025-06
Sun Pharmaceuticals INR 859M 139.6M 2026-03
TherapeuticsMD USD 20K 25K 2023-09
UPL INR 8.36B 620M 2026-03